首页 > 最新文献

Hypertension Research in Pregnancy最新文献

英文 中文
Obstetric outcomes after instituting a dedicated External Cephalic Version clinic in a large tertiary centre: a 3-year prospective cohort study 在一家大型三级中心建立专门的外部头畸形诊所后的产科结果:一项为期3年的前瞻性队列研究
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-11-30 DOI: 10.14390/jsshp.hrp2020-010
K. Papadakis, S. Myriknas, L. Kidd, Natasha Singh
Aim: External cephalic version (ECV) is the main intervention for facilitating vaginal birth without increasing intrapartum mortality and neonatal morbidity in term breech pregnancies. We appraise the hypothesis that the introduction of a specialised ECV clinic reduces preventable caesareans without compromising neonatal well-being. Methods: This is a prospective cohort study over a period of 3 years. Data were collected via attendance in the ECV clinic and women were followed up until the delivery and the postnatal period. Obstetric and neonatal notes were reviewed in order to assess obstetric data and fetal outcomes. Results: 181 suitable women with singleton pregnancy were included in our sample, from which 28 opted for elective caesarean delivery. 81% of the eligible women underwent an ECV. From the 120 ECVs performed, 78 women were nulliparous and 42 multiparous. The ECV was successful in a total of 64 cases (54%), 49% in nulliparous and 62% in multiparous women. Following that, 78% delivered vaginally of which 25% needed instrumental delivery. There were not any adverse events during the ECVs and no woman underwent emergency caesarean section for fetal distress due to the procedure. Conclusion: Our experience favours the ECV clinic, as it improves vaginal delivery rates with no obvious maternal and neonatal compromise. Cost-effectiveness and maternal satisfaction levels remain unknown. There is still room for improvement in detection, uptake and success ECV rates.
目的:在不增加足月臀位妊娠产时死亡率和新生儿发病率的情况下,头外翻转(ECV)是促进阴道分娩的主要干预措施。我们评估了这样一种假设,即引入专门的ECV诊所可以在不影响新生儿健康的情况下减少可预防的剖腹产。方法:这是一项为期3年的前瞻性队列研究。通过在ECV诊所就诊收集数据,并对女性进行随访,直到分娩和产后。对产科和新生儿记录进行了审查,以评估产科数据和胎儿结局。结果:181名适合单胎妊娠的女性被纳入我们的样本,其中28人选择了选择性剖腹产。81%符合条件的妇女接受了ECV。在120例ECV中,78例为未产妇,42例为多胎。ECV在总共64例(54%)中成功,在未产妇中成功49%,在多胎妇女中成功62%。之后,78%通过阴道分娩,其中25%需要器械分娩。ECVs期间没有发生任何不良事件,也没有女性因该手术导致胎儿窘迫而接受紧急剖腹产手术。结论:我们的经验有利于ECV临床,因为它可以提高阴道分娩率,而不会对产妇和新生儿造成明显的损害。成本效益和产妇满意度仍然未知。ECV的检测率、吸收率和成功率仍有提高的空间。
{"title":"Obstetric outcomes after instituting a dedicated External Cephalic Version clinic in a large tertiary centre: a 3-year prospective cohort study","authors":"K. Papadakis, S. Myriknas, L. Kidd, Natasha Singh","doi":"10.14390/jsshp.hrp2020-010","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2020-010","url":null,"abstract":"Aim: External cephalic version (ECV) is the main intervention for facilitating vaginal birth without increasing intrapartum mortality and neonatal morbidity in term breech pregnancies. We appraise the hypothesis that the introduction of a specialised ECV clinic reduces preventable caesareans without compromising neonatal well-being. Methods: This is a prospective cohort study over a period of 3 years. Data were collected via attendance in the ECV clinic and women were followed up until the delivery and the postnatal period. Obstetric and neonatal notes were reviewed in order to assess obstetric data and fetal outcomes. Results: 181 suitable women with singleton pregnancy were included in our sample, from which 28 opted for elective caesarean delivery. 81% of the eligible women underwent an ECV. From the 120 ECVs performed, 78 women were nulliparous and 42 multiparous. The ECV was successful in a total of 64 cases (54%), 49% in nulliparous and 62% in multiparous women. Following that, 78% delivered vaginally of which 25% needed instrumental delivery. There were not any adverse events during the ECVs and no woman underwent emergency caesarean section for fetal distress due to the procedure. Conclusion: Our experience favours the ECV clinic, as it improves vaginal delivery rates with no obvious maternal and neonatal compromise. Cost-effectiveness and maternal satisfaction levels remain unknown. There is still room for improvement in detection, uptake and success ECV rates.","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44597837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert consensus: Indication criteria and screening strategy for preeclampsia using the serum sFlt-1/PlGF ratio at 18–36 weeks of gestation in women at imminent/basal risk of preeclampsia under insurance coverage 专家共识:在保险范围内有先兆子痫迫在眉睫/基础风险的妇女中,使用妊娠18-36周血清sFlt-1/PlGF比率的先兆子痫适应症标准和筛查策略
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-11-30 DOI: 10.14390/jsshp.hrp2020-009
A. Ohkuchi, E. Kondoh, Tatsuo Yamamoto, H. Seki, S. Saito, S. Makino, Miwa Nishida, T. Kikuchi
ratio of tyrosine to placental growth factor (sFlt-1/PlGF ratio), a flow diagram for the short-term prediction of preeclampsia (PE) using the sFlt-1/PlGF ratio in women at imminent/basal risk of preeclampsia. sFlt-1/PlGF flow for PE using ratio in at risk of PE at of consensus of at Web Meeting” held on expert consensus, appropriate perinatal care under close observation is recommended for women at imminent/basal risk of PE who have an sFlt-1/PlGF ratio > 38 at recruitment. For women at imminent risk of PE who have an sFlt-1/PlGF ratio ≤ 38 at recruitment, shortening the interval between maternal check-ups is recommended, along with re-evaluation of the sFlt-1/PlGF ratio 1–4 weeks after initial blood sampling, based on patient/fetal condition. using the sFlt-1/PlGF ratio under insurance in at of and
酪氨酸与胎盘生长因子的比率(sFlt-1/PlGF比率),这是使用sFlt-1/PlGF比率在先兆子痫即将发生/基础风险妇女中短期预测先兆子痫(PE)的流程图。sFlt-1/PlGF用于PE的流量使用在根据专家共识举行的网络会议上达成共识的PE风险中的比率,建议在密切观察下对招募时sFlt-1/PlGF比率>38的有PE迫在眉睫/基础风险的妇女进行适当的围产期护理。对于招募时sFlt-1/PlGF比值≤38的PE高危女性,建议缩短产妇检查间隔,并根据患者/胎儿状况,在初次采血1-4周后重新评估sFlt-1/PlGF比值。在和的保险下使用sFlt-1/PlGF比率
{"title":"Expert consensus: Indication criteria and screening strategy for preeclampsia using the serum sFlt-1/PlGF ratio at 18–36 weeks of gestation in women at imminent/basal risk of preeclampsia under insurance coverage","authors":"A. Ohkuchi, E. Kondoh, Tatsuo Yamamoto, H. Seki, S. Saito, S. Makino, Miwa Nishida, T. Kikuchi","doi":"10.14390/jsshp.hrp2020-009","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2020-009","url":null,"abstract":"ratio of tyrosine to placental growth factor (sFlt-1/PlGF ratio), a flow diagram for the short-term prediction of preeclampsia (PE) using the sFlt-1/PlGF ratio in women at imminent/basal risk of preeclampsia. sFlt-1/PlGF flow for PE using ratio in at risk of PE at of consensus of at Web Meeting” held on expert consensus, appropriate perinatal care under close observation is recommended for women at imminent/basal risk of PE who have an sFlt-1/PlGF ratio > 38 at recruitment. For women at imminent risk of PE who have an sFlt-1/PlGF ratio ≤ 38 at recruitment, shortening the interval between maternal check-ups is recommended, along with re-evaluation of the sFlt-1/PlGF ratio 1–4 weeks after initial blood sampling, based on patient/fetal condition. using the sFlt-1/PlGF ratio under insurance in at of and","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49061075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expected reduction in the number of births due to the COVID-19 pandemic and proposal for countermeasures 2019冠状病毒病大流行对出生人数减少的预期及对策建议
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-11-30 DOI: 10.14390/jsshp.hrp2020-019
J. Takeda, M. Nakabayashi†
To the Editor: In recent years, Japan has faced a rapidly and continuously declining birth rate similar to or even worse than those of other developed countries. The global COVID-19 pandemic in 2020 has further exacerbated this. Our purpose for writing this letter is to raise awareness on the relationship between the COVID-19 pandemic and declining birth rate in Japan. The COVID-19 pandemic in Japan noticeably worsened at the end of March 2020, and with the government’s declaration of a state of emergency, people voluntarily refrained from going outside unless urgently needed until June. If women became pregnant during this period, their estimated due dates would be in the first three months of 2021. Thus, we investigated the number of delivery appointments for these three months. The number of births in 2019 was 865,239, which amounts to a 5.8% decrease compared to the year before.1) If this decreasing trend continues this year, then the number of delivery appointments at delivery facilities should decrease by about 5%. However, in reality, the decrease is even greater (Figure). The difference of approximately 10–25% is not the result of a spontaneous decrease in the number of births, but likely due to another factor. Part of this difference might be explained by the temporary postponing of assisted reproductive technology in view of the statement set forth by the Japan Society for Reproductive Medicine (April 1, 2020).2) However, the entire difference cannot be solely pinned on this. Hospitals which provided data for this study are tertiary hospitals, as well as perinatal medical centers that take on cases of maternal transport or fetal congenital anomalies, which might be included in delivery appointments. However, given the magnitude of the difference, we view the avoidance of becoming pregnant due to fears of COVID-19 to be a major contributing factor. We propose the following three measures. First, a national survey of birth appointments should be conducted. Second, trends of decreasing birth appointments should be closely and continuously monitored. Lastly, the public should be provided with accurate information regarding the relationship between maternal and neonatal COVID19 infection. For the first measure, the use of data limited to tertiary hospitals and urban areas paints the picture that the COVID-19 situation is worse compared to rural areas. Thus, data from rural areas and local clinics should also be examined to determine whether similar trends are observed. For the second measure, the postponement of assisted reproductive technology was temporary and has now returned to normal after another announcement from Ch an ge s o f b irt h ap po in tm en ts (% )
致编者:近年来,日本面临着与其他发达国家相似甚至更糟的出生率快速持续下降的问题。2020年的全球COVID-19大流行进一步加剧了这种情况。我们写这封信的目的是为了提高人们对新冠肺炎大流行与日本出生率下降之间关系的认识。2020年3月底,日本的新冠肺炎疫情明显恶化,随着政府宣布进入紧急状态,直到6月,除非有紧急情况,否则人们自愿避免外出。如果女性在此期间怀孕,预计预产期将在2021年前三个月。因此,我们调查了这三个月的分娩预约数量。2019年的出生人数为865239人,与前一年相比减少了5.8%。1)如果今年这种下降趋势继续下去,那么在分娩机构的分娩预约次数应该会减少约5%。然而,在现实中,降幅甚至更大(图)。大约10-25%的差异不是出生数量自然减少的结果,而可能是由于另一个因素。鉴于日本生殖医学学会(2020年4月1日)发表的声明,这种差异的部分原因可能是辅助生殖技术的暂时推迟。2)然而,不能将整个差异完全归咎于此。为这项研究提供数据的医院是三级医院,以及接受产妇转运或胎儿先天性异常病例的围产期医疗中心,这可能包括在分娩预约中。然而,鉴于差异之大,我们认为由于担心COVID-19而避免怀孕是一个主要因素。我们提出以下三点措施。首先,应该在全国范围内进行出生预约调查。其次,应密切和持续监测分娩预约减少的趋势。最后,应向公众提供有关孕产妇和新生儿感染covid - 19之间关系的准确信息。在第一项措施中,使用仅限于三级医院和城市地区的数据显示,与农村地区相比,2019冠状病毒病的情况更糟。因此,还应检查农村地区和地方诊所的数据,以确定是否观察到类似的趋势。对于第二项措施,辅助生殖技术的推迟是暂时的,在中国政府再次宣布推迟使用辅助生殖技术后,现在已经恢复正常。
{"title":"Expected reduction in the number of births due to the COVID-19 pandemic and proposal for countermeasures","authors":"J. Takeda, M. Nakabayashi†","doi":"10.14390/jsshp.hrp2020-019","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2020-019","url":null,"abstract":"To the Editor: In recent years, Japan has faced a rapidly and continuously declining birth rate similar to or even worse than those of other developed countries. The global COVID-19 pandemic in 2020 has further exacerbated this. Our purpose for writing this letter is to raise awareness on the relationship between the COVID-19 pandemic and declining birth rate in Japan. The COVID-19 pandemic in Japan noticeably worsened at the end of March 2020, and with the government’s declaration of a state of emergency, people voluntarily refrained from going outside unless urgently needed until June. If women became pregnant during this period, their estimated due dates would be in the first three months of 2021. Thus, we investigated the number of delivery appointments for these three months. The number of births in 2019 was 865,239, which amounts to a 5.8% decrease compared to the year before.1) If this decreasing trend continues this year, then the number of delivery appointments at delivery facilities should decrease by about 5%. However, in reality, the decrease is even greater (Figure). The difference of approximately 10–25% is not the result of a spontaneous decrease in the number of births, but likely due to another factor. Part of this difference might be explained by the temporary postponing of assisted reproductive technology in view of the statement set forth by the Japan Society for Reproductive Medicine (April 1, 2020).2) However, the entire difference cannot be solely pinned on this. Hospitals which provided data for this study are tertiary hospitals, as well as perinatal medical centers that take on cases of maternal transport or fetal congenital anomalies, which might be included in delivery appointments. However, given the magnitude of the difference, we view the avoidance of becoming pregnant due to fears of COVID-19 to be a major contributing factor. We propose the following three measures. First, a national survey of birth appointments should be conducted. Second, trends of decreasing birth appointments should be closely and continuously monitored. Lastly, the public should be provided with accurate information regarding the relationship between maternal and neonatal COVID19 infection. For the first measure, the use of data limited to tertiary hospitals and urban areas paints the picture that the COVID-19 situation is worse compared to rural areas. Thus, data from rural areas and local clinics should also be examined to determine whether similar trends are observed. For the second measure, the postponement of assisted reproductive technology was temporary and has now returned to normal after another announcement from Ch an ge s o f b irt h ap po in tm en ts (% )","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42075602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The current status of and measures against maternal suicide in Japan 日本孕产妇自杀现状及对策
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-11-30 DOI: 10.14390/jsshp.hrp2020-005
S. Takeda
Rapid progress in perinatal care in recent decades has led to a dramatic decline in perinatal, neonatal, and maternal mortality (excluding suicides), and achieved remarkable improvements in obstetrical outcomes in Japan. However, while maternal mortality had been on a continuous and steady decline up until 2007 (3.1/100,000 total births), the rate has been fluctuating since then (e.g., 2.7/100,000 in 2014, 3.4/100,000 in 2016). This is likely attributed to a variety of factors that have emerged in the past 20 years due to changes in the environment and social situation surrounding women, such as later marriage and rise in maternal age. In Western countries, “late maternal deaths” occurring between 42 days and one year after delivery are considered to be just as important as “maternal deaths,” i.e., deaths during pregnancy or within 42 days of termination of pregnancy. In particular, suicides attributable to psychiatric disorders have become a serious issue among women less than one year postpartum. However, in Japan, the actual number of deaths by suicide is unknown, since neither death certificates nor postmortem certificates include information on pregnancy and delivery. Despite the fact that the total number of suicide deaths in Japan is known, whether such deaths are associated with perinatal mental issues or not is unclear, and thus, no measures have been taken. Untreated perinatal depression and psychiatric disorders not only cause issues such as suicide, but are also related to pediatric developmental and mental disorders, neglect, and/or child abuse due to impaired nurturing ability. Suicide rates among pregnant and parturient women in Osaka, Tokyo, and Mie are much higher than those of the UK, the US, and Sweden. There is an urgent need to establish a regional support system that facilitates interactions among the obstetrical, pediatric, psychiatric field, and local administrations for monitoring and supporting mothers and infants, as well as a system that allows families, schools, and society to support young people, in order to realize improved preconception health care.
近几十年来,围产期护理的快速进步导致围产期、新生儿和孕产妇死亡率(不包括自杀)大幅下降,并在日本的产科结果方面取得了显著改善。然而,尽管截至2007年,孕产妇死亡率一直在持续稳步下降(出生总数为3.1/10万),但自那时以来,这一比率一直在波动(例如,2014年为2.7/10万,2016年为3.4/10万)。这可能归因于过去20年中由于妇女周围环境和社会状况的变化而出现的各种因素,例如晚婚和产妇年龄的上升。在西方国家,发生在产后42天至一年之间的“晚期孕产妇死亡”被认为与“孕产妇死亡”同等重要,即妊娠期间或终止妊娠42天内的死亡。特别是,在产后不到一年的妇女中,精神障碍导致的自杀已成为一个严重问题。然而,在日本,自杀死亡的实际人数尚不清楚,因为死亡证明和尸检证明都没有包括怀孕和分娩的信息。尽管日本自杀死亡的总人数是已知的,但这种死亡是否与围产期精神问题有关尚不清楚,因此没有采取任何措施。未经治疗的围产期抑郁症和精神障碍不仅会导致自杀等问题,还与儿童发育和精神障碍、忽视和/或因养育能力受损而虐待儿童有关。大阪、东京和三重县孕妇和产妇的自杀率远高于英国、美国和瑞典。迫切需要建立一个区域支持系统,促进产科、儿科、精神科和地方行政部门之间的互动,以监测和支持母亲和婴儿,并建立一个允许家庭、学校和社会支持年轻人的系统,以实现更好的先入为主的医疗保健。
{"title":"The current status of and measures against maternal suicide in Japan","authors":"S. Takeda","doi":"10.14390/jsshp.hrp2020-005","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2020-005","url":null,"abstract":"Rapid progress in perinatal care in recent decades has led to a dramatic decline in perinatal, neonatal, and maternal mortality (excluding suicides), and achieved remarkable improvements in obstetrical outcomes in Japan. However, while maternal mortality had been on a continuous and steady decline up until 2007 (3.1/100,000 total births), the rate has been fluctuating since then (e.g., 2.7/100,000 in 2014, 3.4/100,000 in 2016). This is likely attributed to a variety of factors that have emerged in the past 20 years due to changes in the environment and social situation surrounding women, such as later marriage and rise in maternal age. In Western countries, “late maternal deaths” occurring between 42 days and one year after delivery are considered to be just as important as “maternal deaths,” i.e., deaths during pregnancy or within 42 days of termination of pregnancy. In particular, suicides attributable to psychiatric disorders have become a serious issue among women less than one year postpartum. However, in Japan, the actual number of deaths by suicide is unknown, since neither death certificates nor postmortem certificates include information on pregnancy and delivery. Despite the fact that the total number of suicide deaths in Japan is known, whether such deaths are associated with perinatal mental issues or not is unclear, and thus, no measures have been taken. Untreated perinatal depression and psychiatric disorders not only cause issues such as suicide, but are also related to pediatric developmental and mental disorders, neglect, and/or child abuse due to impaired nurturing ability. Suicide rates among pregnant and parturient women in Osaka, Tokyo, and Mie are much higher than those of the UK, the US, and Sweden. There is an urgent need to establish a regional support system that facilitates interactions among the obstetrical, pediatric, psychiatric field, and local administrations for monitoring and supporting mothers and infants, as well as a system that allows families, schools, and society to support young people, in order to realize improved preconception health care.","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49540733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Predictive Accuracy of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for Preeclampsia in Japan: A Systematic Review 可溶性FMS样酪氨酸激酶1/胎盘生长因子比值对日本先兆子痫预测准确性的系统评价
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-11-01 DOI: 10.14390/jsshp.hrp2020-012
Tomomi Yamazaki, A. Cerdeira, S. Agrawal, I. Koh, J. Sugimoto, M. Vatish, Y. Kudo
Preeclampsia is a major complication of pregnancy and is associated with significant fetal and maternal morbidity and mortality. Timely prediction of preeclampsia facilitates referral of potential patients to an adequate tertiary center, which helps reduce adverse outcomes associated with the disease. Moreover, by accurately ruling out preeclampsia, patients can be discharged safely and relieved of anxiety. Numerous candidate biomarkers have been proposed for the diagnosis and prediction of preeclampsia. Among these, maternal circulating factors such as soluble FMS-like tyrosine kinase-1 (sFlt-1), an anti-angiogenic factor, and placental growth factor (PlGF), an angiogenic factor, are considered the most promising. Measuring these factors as a ratio allows assessment of the angiogenic imbalance that characterizes incipient or overt preeclampsia. The sFlt-1/PlGF ratio increases before the onset of preeclampsia and thus may help predict the disease. The test is used as a predictive tool in several countries but not yet routinely performed in Japanese hospitals. We performed a systematic review of studies that assessed the performance of the sFlt-1/PlGF ratio in predicting preeclampsia in Japanese patients. Three studies were included in the systematic review. All studies reported high negative predictive values of the sFlt-1/PlGF ratio (i.e., for ruling out PE), in agreement with the current evidence of the test performance worldwide. The sFlt-1/PlGF ratio could be of significant relevance in the Japanese population.
子痫前期是妊娠的主要并发症,与胎儿和产妇的发病率和死亡率相关。及时预测子痫前期有利于潜在患者转介到适当的三级中心,这有助于减少与疾病相关的不良后果。此外,通过准确地排除子痫前期,患者可以安全出院,减轻焦虑。许多候选的生物标志物已被提出用于诊断和预测先兆子痫。其中,母体循环因子,如可溶性fms样酪氨酸激酶-1 (sFlt-1),一种抗血管生成因子,和胎盘生长因子(PlGF),一种血管生成因子,被认为是最有希望的。测量这些因素的比率可以评估早期或显性子痫前期血管生成失衡的特征。sFlt-1/PlGF比值在子痫前期发病前升高,因此可能有助于预测该疾病。该测试在一些国家被用作预测工具,但尚未在日本医院常规进行。我们对评估sFlt-1/PlGF比值在预测日本患者子痫前期表现的研究进行了系统回顾。本系统评价纳入了三项研究。所有研究都报告了sFlt-1/PlGF比率的高阴性预测值(即排除PE),这与目前全球范围内测试性能的证据一致。sFlt-1/PlGF比值在日本人群中可能具有重要的相关性。
{"title":"Predictive Accuracy of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for Preeclampsia in Japan: A Systematic Review","authors":"Tomomi Yamazaki, A. Cerdeira, S. Agrawal, I. Koh, J. Sugimoto, M. Vatish, Y. Kudo","doi":"10.14390/jsshp.hrp2020-012","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2020-012","url":null,"abstract":"Preeclampsia is a major complication of pregnancy and is associated with significant fetal and maternal morbidity and mortality. Timely prediction of preeclampsia facilitates referral of potential patients to an adequate tertiary center, which helps reduce adverse outcomes associated with the disease. Moreover, by accurately ruling out preeclampsia, patients can be discharged safely and relieved of anxiety. Numerous candidate biomarkers have been proposed for the diagnosis and prediction of preeclampsia. Among these, maternal circulating factors such as soluble FMS-like tyrosine kinase-1 (sFlt-1), an anti-angiogenic factor, and placental growth factor (PlGF), an angiogenic factor, are considered the most promising. Measuring these factors as a ratio allows assessment of the angiogenic imbalance that characterizes incipient or overt preeclampsia. The sFlt-1/PlGF ratio increases before the onset of preeclampsia and thus may help predict the disease. The test is used as a predictive tool in several countries but not yet routinely performed in Japanese hospitals. We performed a systematic review of studies that assessed the performance of the sFlt-1/PlGF ratio in predicting preeclampsia in Japanese patients. Three studies were included in the systematic review. All studies reported high negative predictive values of the sFlt-1/PlGF ratio (i.e., for ruling out PE), in agreement with the current evidence of the test performance worldwide. The sFlt-1/PlGF ratio could be of significant relevance in the Japanese population.","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43340211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pulmonary arteriovenous malformations with deep vein thrombosis and hypoxemia after delivery as a differential diagnosis of pulmonary embolism: A case report 肺动静脉畸形合并深静脉血栓形成和产后低氧血症对肺栓塞的鉴别诊断:一例报告
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-10-01 DOI: 10.14390/jsshp.hrp2020-014
T. Nagao, Midori Funakura, M. Saito, H. Hyodo
Pulmonary arteriovenous malformation (PAVMs) is a rare condition characterized by abnormal vascular connections between pulmonary arteries and veins. Increased pulmonary blood flow during pregnancy can exacerbate intrapulmonary shunt, which can cause stroke or pulmonary hemorrhage and lead to maternal death, miscarriage, and fetal growth restriction. PAVMs may be misdiagnosed, as their prominent symptoms are similar to those of pulmonary embolism (PE). We report herein a case of a 20-year-old woman diagnosed with PAVMs, who was initially suspected to have PE. She developed hypoxemia and deep vein thrombosis immediately after delivery that resulted in fetal growth restriction and asymptomatic acute cerebral infarction. Undiagnosed chronic hypoxemia was considered as a differential diagnosis of PE, since the patient showed signs of chronic hypoxia such as clubbing and cyanosis. Our findings underscore the importance of thorough systemic assessment during the first visit of patients with suspected PE.
肺动静脉畸形是一种罕见的疾病,其特征是肺动脉和静脉之间的血管连接异常。妊娠期肺血流量增加会加剧肺内分流,导致中风或肺出血,并导致产妇死亡、流产和胎儿生长受限。PAVM可能被误诊,因为它们的突出症状与肺栓塞(PE)相似。我们报告了一例20岁的女性被诊断为PAVM,最初被怀疑患有PE。她在分娩后立即出现低氧血症和深静脉血栓形成,导致胎儿生长受限和无症状急性脑梗死。未确诊的慢性低氧血症被认为是PE的鉴别诊断,因为患者表现出慢性缺氧的迹象,如发绀和发绀。我们的研究结果强调了在疑似PE患者的首次就诊期间进行彻底的系统评估的重要性。
{"title":"Pulmonary arteriovenous malformations with deep vein thrombosis and hypoxemia after delivery as a differential diagnosis of pulmonary embolism: A case report","authors":"T. Nagao, Midori Funakura, M. Saito, H. Hyodo","doi":"10.14390/jsshp.hrp2020-014","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2020-014","url":null,"abstract":"Pulmonary arteriovenous malformation (PAVMs) is a rare condition characterized by abnormal vascular connections between pulmonary arteries and veins. Increased pulmonary blood flow during pregnancy can exacerbate intrapulmonary shunt, which can cause stroke or pulmonary hemorrhage and lead to maternal death, miscarriage, and fetal growth restriction. PAVMs may be misdiagnosed, as their prominent symptoms are similar to those of pulmonary embolism (PE). We report herein a case of a 20-year-old woman diagnosed with PAVMs, who was initially suspected to have PE. She developed hypoxemia and deep vein thrombosis immediately after delivery that resulted in fetal growth restriction and asymptomatic acute cerebral infarction. Undiagnosed chronic hypoxemia was considered as a differential diagnosis of PE, since the patient showed signs of chronic hypoxia such as clubbing and cyanosis. Our findings underscore the importance of thorough systemic assessment during the first visit of patients with suspected PE.","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44408197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advantages of contrast-enhanced ultrasonography and uterine balloon tamponade during intrauterine evacuation of retained products of conception 超声造影和子宫球囊填塞在妊娠残余物宫内清除中的优势
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-07-27 DOI: 10.14390/jsshp.hrp2020-004
Rie Seyama, S. Makino, M. Shinohara, Masaya Takahashi, Anna Sato, J. Takeda, S. Takeda, A. Itakura
Aim: Retained products of conception (RPOC) can cause postpartum hemorrhage. However, if intrauterine evacuation is performed for RPOC without adhesion, it can lead to massive hemorrhage due to an inability to identify bleeding points during the operation. Here, we describe the advantages of intrauterine evacuation of RPOC using contrast-enhanced ultrasonography (CE-US), which can identify bleeding points and contribute to successful hemostasis, and uterine balloon tamponade (UBT) in four clinical cases. Methods: We encountered four cases of RPOC and performed intrauterine evacuation combined with CE-US and UBT from 2018 to 2019. The ultrasound contrast agent, perfluorobutane, was infused immediately before the operation. After intrauterine evacuation, the uterine balloon was retained. Results: In all cases, CE-US identified bleeding points immediately, enabling retention of the uterine balloon on the bleeding points and subsequent hemostasis. None of the cases experienced complications the day after the operation.
目的:妊娠残留物(RPOC)可引起产后出血。然而,如果在没有粘连的情况下对RPOC进行宫内引流,由于术中无法识别出血点,可能导致大出血。在这里,我们描述了四个临床病例中使用对比增强超声(CE-US)在子宫内清除RPOC的优势,它可以识别出血点并有助于成功止血,以及子宫球囊填塞(UBT)。方法:2018 - 2019年收治4例RPOC,联合CE-US和UBT进行宫内引流。术前立即输注超声造影剂全氟丁烷。宫内排出后,保留子宫球囊。结果:在所有病例中,CE-US立即发现出血点,使子宫球囊保留在出血点上并随后止血。所有病例术后均无并发症发生。
{"title":"Advantages of contrast-enhanced ultrasonography and uterine balloon tamponade during intrauterine evacuation of retained products of conception","authors":"Rie Seyama, S. Makino, M. Shinohara, Masaya Takahashi, Anna Sato, J. Takeda, S. Takeda, A. Itakura","doi":"10.14390/jsshp.hrp2020-004","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2020-004","url":null,"abstract":"Aim: Retained products of conception (RPOC) can cause postpartum hemorrhage. However, if intrauterine evacuation is performed for RPOC without adhesion, it can lead to massive hemorrhage due to an inability to identify bleeding points during the operation. Here, we describe the advantages of intrauterine evacuation of RPOC using contrast-enhanced ultrasonography (CE-US), which can identify bleeding points and contribute to successful hemostasis, and uterine balloon tamponade (UBT) in four clinical cases. Methods: We encountered four cases of RPOC and performed intrauterine evacuation combined with CE-US and UBT from 2018 to 2019. The ultrasound contrast agent, perfluorobutane, was infused immediately before the operation. After intrauterine evacuation, the uterine balloon was retained. Results: In all cases, CE-US identified bleeding points immediately, enabling retention of the uterine balloon on the bleeding points and subsequent hemostasis. None of the cases experienced complications the day after the operation.","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44665783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uterine necrosis following uterine artery embolism due to postpartum hemorrhage: A case report and review 产后出血所致子宫动脉栓塞致子宫坏死1例报告及复习
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-07-07 DOI: 10.14390/jsshp.hrp2020-002
Hiroto Hirashima, K. Kaminaga, Y. Koyashiki, K. Tabata, R. Usui, A. Ohkuchi
Uterine necrosis after uterine artery embolization (UAE) for postpartum hemorrhage (PPH) is relatively rare. A 29-year-old primiparous woman had a diamniotic dichorionic twin pregnancy following frozen blastocyst transfer. She developed preeclampsia at 34 +3 weeks, and cesarean section was performed due to lung edema at 35 +2 weeks. UAE was performed using a gelatin sponge 3 hours after the operation due to PPH; however, the hemorrhage continued, and we performed a second UAE using n-butyl-2-cyanoacrylate. Uterine subinvolution continued after the second UAE, and her fever recurred 11 days after the operation. Magnetic resonance imaging suggested uterine necrosis 14 days after the operation, resulting in hysterectomy. The present study reviewed 17 cases of uterine necrosis following UAE in women with PPH, fever, abdominal/pelvic pain and found that delayed appearance of various symptoms was common. A long-lasting subinvolution may be a novel specific feature of uterine necrosis in women with UAE due to PPH.
子宫动脉栓塞术(UAE)治疗产后出血(PPH)后子宫坏死是比较少见的。一例29岁初产妇在冷冻囊胚移植后发生双羊膜双绒毛膜双胎妊娠。34 +3周出现先兆子痫,35 +2周因肺水肿行剖宫产。因PPH术后3小时用明胶海绵行UAE;然而,出血仍在继续,我们使用正丁基-2-氰基丙烯酸酯进行了第二次UAE。第二次UAE术后子宫复旧持续,术后11天出现发热。术后14天mri提示子宫坏死,行子宫切除术。本研究回顾了17例伴有PPH、发热、腹部/盆腔疼痛的妇女在UAE后出现子宫坏死的病例,发现各种症状的延迟出现是常见的。长时间的退化可能是PPH所致UAE妇女子宫坏死的一个新的特殊特征。
{"title":"Uterine necrosis following uterine artery embolism due to postpartum hemorrhage: A case report and review","authors":"Hiroto Hirashima, K. Kaminaga, Y. Koyashiki, K. Tabata, R. Usui, A. Ohkuchi","doi":"10.14390/jsshp.hrp2020-002","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2020-002","url":null,"abstract":"Uterine necrosis after uterine artery embolization (UAE) for postpartum hemorrhage (PPH) is relatively rare. A 29-year-old primiparous woman had a diamniotic dichorionic twin pregnancy following frozen blastocyst transfer. She developed preeclampsia at 34 +3 weeks, and cesarean section was performed due to lung edema at 35 +2 weeks. UAE was performed using a gelatin sponge 3 hours after the operation due to PPH; however, the hemorrhage continued, and we performed a second UAE using n-butyl-2-cyanoacrylate. Uterine subinvolution continued after the second UAE, and her fever recurred 11 days after the operation. Magnetic resonance imaging suggested uterine necrosis 14 days after the operation, resulting in hysterectomy. The present study reviewed 17 cases of uterine necrosis following UAE in women with PPH, fever, abdominal/pelvic pain and found that delayed appearance of various symptoms was common. A long-lasting subinvolution may be a novel specific feature of uterine necrosis in women with UAE due to PPH.","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48165591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Over-expanded lower uterine segment: a cause of intrauterine balloon tamponade failure 子宫下段过度扩张:宫内球囊填塞失败的原因之一
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-06-10 DOI: 10.14390/jsshp.hrp2020-001
Liangcheng Wang, Kohei Hamamoto, Azusa Kimura, Aya Ishiguro, Isao Horiuchi, K. Takagi
Intrauterine balloon tamponade (IBT) is widely used for treating obstetric hemorrhage. However, only a few reports on IBT failure exist. We report a case of IBT failure caused by an over-expanded lower uterine segment (LUS). A 30-year-old woman with twin pregnancy presented with bleeding after cesarean section. During surgery, uterine atony was observed; however, intravenous administration of oxytocin and ergometrine resolved the condition. Continuous hemorrhage was observed postoperatively, despite the administration of uterotonics and uterine massage. Although IBT was performed, the bleeding persisted, as recognized from the drainage fluid. Enhanced computed tomography revealed that the bleeding spot could not be compressed by the inflated balloon due to the over-expanded LUS. The balloon was removed; uterine artery embolization was required to achieve hemostasis. Our experience indicated that over-expanded LUS could cause IBT failure. If bleeding continues post-IBT replacement and an over-expanded LUS is observed, alternative treatments should be promptly
宫内球囊填塞术(IBT)广泛用于治疗产科出血。然而,只有少数关于IBT失败的报告存在。我们报告了一例因子宫下段(LUS)过度扩张引起的IBT衰竭。一位30岁的双胎妊娠妇女在剖宫产后出现出血。术中观察到子宫收缩乏力;然而,静脉注射催产素和麦角新碱解决了这种情况。术后观察到持续出血,尽管使用了子宫补剂和子宫按摩。尽管进行了IBT,但从引流液中可以看出,出血仍然存在。增强计算机断层扫描显示,由于LUS过度膨胀,膨胀的球囊无法压缩出血点。气球被移走了;需要子宫动脉栓塞止血。我们的经验表明,过度扩展的LUS可能导致IBT失败。如果IBT置换术后出血持续,并且观察到LUS过度扩张,则应立即进行替代治疗
{"title":"Over-expanded lower uterine segment: a cause of intrauterine balloon tamponade failure","authors":"Liangcheng Wang, Kohei Hamamoto, Azusa Kimura, Aya Ishiguro, Isao Horiuchi, K. Takagi","doi":"10.14390/jsshp.hrp2020-001","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2020-001","url":null,"abstract":"Intrauterine balloon tamponade (IBT) is widely used for treating obstetric hemorrhage. However, only a few reports on IBT failure exist. We report a case of IBT failure caused by an over-expanded lower uterine segment (LUS). A 30-year-old woman with twin pregnancy presented with bleeding after cesarean section. During surgery, uterine atony was observed; however, intravenous administration of oxytocin and ergometrine resolved the condition. Continuous hemorrhage was observed postoperatively, despite the administration of uterotonics and uterine massage. Although IBT was performed, the bleeding persisted, as recognized from the drainage fluid. Enhanced computed tomography revealed that the bleeding spot could not be compressed by the inflated balloon due to the over-expanded LUS. The balloon was removed; uterine artery embolization was required to achieve hemostasis. Our experience indicated that over-expanded LUS could cause IBT failure. If bleeding continues post-IBT replacement and an over-expanded LUS is observed, alternative treatments should be promptly","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43870681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left ventricular hypertrophy in Japanese pregnant women with chronic hypertension predicts blood pressure elevation during pregnancy 日本慢性高血压孕妇左心室肥厚预示妊娠期血压升高
IF 0.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2020-03-30 DOI: 10.14390/jsshp.hrp2019-016
A. Nakanishi, C. Kamiya, M. Sawada, T. Shionoiri, T. Konishi, C. Horiuchi, M. Tsuritani, N. Iwanaga, J. Yoshimatsu
Aim: The influence of cardiovascular changes resulting from hypertension on the course of pregnancy is unclear. The purpose of this study was to evaluate the influence of cardiovascular changes as detected by echocardiography on the course of pregnancy with chronic hypertension. Methods: This retrospective cohort study targeted women with a singleton pregnancy and chronic hypertension during the period between January 1, 2010 and December 31, 2018. We compared echocardiographic values between subjects with blood pressure (BP) elevation (BP elevation group) and normotensive subjects (control group) during pregnancy. Results: Twenty-nine hypertensive pregnant women were eligible for this study (14 subjects in the BP elevation group and 15 subjects in the control group). Left ventricular posterior wall thickness (PWT) and left ventricular mass index (LVMI) tended to be greater in the BP elevation group compared to the control group, but the differences were not significant. In the sub-cohort of subjects aged ≥ 35 years, PWT and LVMI were significantly greater in the BP elevation group compared to the control group. Conclusions: Left ventricular hypertrophy (LVH) in pregnant women with chronic hypertension may be a predictor of BP elevation during pregnancy.
目的:高血压引起的心血管变化对妊娠过程的影响尚不清楚。本研究的目的是评估超声心动图检测的心血管变化对慢性高血压妊娠过程的影响。方法:这项回顾性队列研究针对的是2010年1月1日至2018年12月31日期间单胎妊娠和慢性高血压的女性。我们比较了妊娠期血压(BP)升高受试者(BP升高组)和血压正常受试者的超声心动图值。结果:29名高血压孕妇符合本研究条件(血压升高组14名,对照组15名)。与对照组相比,血压升高组的左心室后壁厚度(PWT)和左心室质量指数(LVMI)往往更大,但差异不显著。在年龄≥35岁的受试者的子队列中,与对照组相比,血压升高组的PWT和LVMI显著更高。结论:慢性高血压孕妇的左心室肥大(LVH)可能是妊娠期血压升高的预测指标。
{"title":"Left ventricular hypertrophy in Japanese pregnant women with chronic hypertension predicts blood pressure elevation during pregnancy","authors":"A. Nakanishi, C. Kamiya, M. Sawada, T. Shionoiri, T. Konishi, C. Horiuchi, M. Tsuritani, N. Iwanaga, J. Yoshimatsu","doi":"10.14390/jsshp.hrp2019-016","DOIUrl":"https://doi.org/10.14390/jsshp.hrp2019-016","url":null,"abstract":"Aim: The influence of cardiovascular changes resulting from hypertension on the course of pregnancy is unclear. The purpose of this study was to evaluate the influence of cardiovascular changes as detected by echocardiography on the course of pregnancy with chronic hypertension. Methods: This retrospective cohort study targeted women with a singleton pregnancy and chronic hypertension during the period between January 1, 2010 and December 31, 2018. We compared echocardiographic values between subjects with blood pressure (BP) elevation (BP elevation group) and normotensive subjects (control group) during pregnancy. Results: Twenty-nine hypertensive pregnant women were eligible for this study (14 subjects in the BP elevation group and 15 subjects in the control group). Left ventricular posterior wall thickness (PWT) and left ventricular mass index (LVMI) tended to be greater in the BP elevation group compared to the control group, but the differences were not significant. In the sub-cohort of subjects aged ≥ 35 years, PWT and LVMI were significantly greater in the BP elevation group compared to the control group. Conclusions: Left ventricular hypertrophy (LVH) in pregnant women with chronic hypertension may be a predictor of BP elevation during pregnancy.","PeriodicalId":42505,"journal":{"name":"Hypertension Research in Pregnancy","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48273903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hypertension Research in Pregnancy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1